Pluristem Therapeutics, Inc. (PSTI) financial statements (2022 and earlier)

Company profile

Business Address MATAM ADVANCED TECHNOLOGY PARK
HAIFA, 3508409
State of Incorp. NV
Fiscal Year End June 30
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:68,84888,21958,99224,79529,90026,10614,793
Cash and cash equivalents18,71531,2418,2704,1068,8214,7076,223
Short-term investments39,46833,70937,51419,59921,0796,2358,570
Other undisclosed cash, cash equivalents, and short-term investments10,66523,26913,2081,090 15,164 
Restricted cash and investments207597555 687559542
Receivables  26125581,0362,228
Other current assets 1,8242,1221,9741,3911,315618
Other undisclosed current assets(8,902)(23,269)(13,234)(523)  17,415
Total current assets:60,15367,37148,46126,37132,03629,01635,596
Noncurrent Assets
Operating lease, right-of-use asset8,4417281,259
Property, plant and equipment8901,4992,5163,8385,6787,2779,216
Long-term investments and receivables10,96523,26912,653398383403363
Long-term investments10,96523,26912,653398383403363
Other noncurrent assets18712101734 
Defined benefit plan, assets for plan benefits 766
Other undisclosed noncurrent assets717664631693846804 
Total noncurrent assets:21,03126,16717,0714,9396,9248,51810,345
TOTAL ASSETS:81,18493,53865,53231,31038,96037,53445,941
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,3198,4675,4756,5116,0513,9364,495
Accounts payable2,6062,5261,9682,2813,2611,9662,705
Accrued liabilities3,7135,9413,0183,7442,2661,4651,369
Employee-related liabilities  489486524505421
Deferred revenue  126
Derivative instruments and hedges, liabilities    243  
Other undisclosed current liabilities3,2763,0502,3861,6472,2541,4781,280
Total current liabilities:9,59511,5177,9878,1588,5485,4145,775
Noncurrent Liabilities
Long-term debt and lease obligation30,76923,950565    
Long-term debt, excluding current maturities23,15823,850     
Operating lease, liability7,611100565
Liabilities, other than long-term debt9809208791,3311,9051,8692,010
Liability, pension and other postretirement and postemployment benefits9809208799501,127940910
Other liabilities   3817789291,100
Total noncurrent liabilities:31,74924,8701,4441,3311,9051,8692,010
Total liabilities:41,34436,3879,4319,48910,4537,2837,785
Stockholders' equity
Stockholders' equity attributable to parent, including:39,84057,15156,10121,82128,50730,25138,156
Common stock   1111
Additional paid in capital392,233387,172336,257272,824244,203217,822198,432
Accumulated other comprehensive income     1,9991,480
Accumulated deficit(352,393)(330,021)(280,156)(251,004)(215,697)(189,571)(161,757)
Stockholders' equity note, subscriptions receivable(39,840)(57,151)(56,101)(21,821)  
Other undisclosed stockholders' equity attributable to parent39,84057,15156,10121,821   
Total stockholders' equity:39,84057,15156,10121,82128,50730,25138,156
TOTAL LIABILITIES AND EQUITY:81,18493,53865,53231,31038,96037,53445,941

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Revenues55552354501222,847
Sublease income 5551
Net investment income   385276122149
Other income    43  
Cost of revenue   (2)(2) (100)
Gross profit: 552352481222,747
Operating expenses(51,300)(51,090)(31,018)(39,039)(37,564)(30,928)(29,342)
Other undisclosed operating income2524121,5193,4553,7852,7873,276
Operating loss:(51,048)(50,623)(29,476)(35,532)(33,731)(28,019)(23,319)
Nonoperating income 3323242257,60520573
Investment income, nonoperating   (105)(264)481(30)
Foreign currency transaction gain (loss), before tax 332(155)(26)52182(174)
Other nonoperating income (expense)   (2)(25) 23
Other undisclosed income from continuing operations before equity method investments, income taxes332      
Loss before gain (loss) on sale of properties:(50,716)(50,291)(29,152)(35,307)(26,126)(27,814)(23,246)
Other undisclosed net income123,029100,156     
Net income (loss):72,31349,865(29,152)(35,307)(26,126)(27,814)(23,246)
Other undisclosed net loss attributable to parent(123,507)(99,730)     
Net loss attributable to parent:(51,194)(49,865)(29,152)(35,307)(26,126)(27,814)(23,246)
Other undisclosed net income available to common stockholders, basic99,73099,730     
Net income (loss) available to common stockholders, diluted:48,53649,865(29,152)(35,307)(26,126)(27,814)(23,246)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net income (loss):72,31349,865(29,152)(35,307)(26,126)(27,814)(23,246)
Other comprehensive income (loss)    (1,999)519(660)
Comprehensive income (loss), net of tax, attributable to parent:72,31349,865(29,152)(35,307)(28,125)(27,295)(23,906)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: